Cataplexy With Narcolepsy: What to Do During an Episode and When to Get Help

Key takeaways
- Cataplexy is a sudden loss of muscle tone during wakefulness, usually triggered by emotion. Awareness is typically preserved.
- During an episode, the priority is preventing injury: move away from hazards and lower yourself into a safe position if possible.
- Someone nearby can protect your head, clear hazards, speak calmly, and avoid restraining you or putting anything in your mouth.
- Seek urgent medical help if there is a serious injury, difficulty breathing, prolonged loss of consciousness, or features that do not fit your usual cataplexy.
- Cataplexy can be addressed medically. Current options include pitolisant, oxybate medicines, and, for adults with narcolepsy type 1, the recently approved orexin receptor agonist oveporexton.
- Laughing at a joke and suddenly feeling your knees weaken can be alarming. So can noticing your jaw drop, your head fall forward, or your grip disappear during a strong emotion.
- These episodes may be cataplexy, a symptom strongly associated with narcolepsy type 1.
- Cataplexy can range from subtle muscle weakness lasting seconds to a more extensive collapse. The experience can be frightening, especially when it is new or when someone nearby has never seen it before.
- The most important goals during an episode are simple: reduce the risk of injury, avoid unnecessary intervention, and recognize when something unusual needs medical attention.
What is cataplexy?
Cataplexy is a sudden, temporary loss of muscle tone during wakefulness that is usually triggered by strong emotion.
Common triggers include:
- laughter;
- excitement;
- surprise;
- anger;
- embarrassment;
- joking;
- other intense emotional reactions.
Unlike fainting, awareness is usually preserved. Someone experiencing cataplexy may still be able to hear and understand what is happening even if speaking or moving becomes temporarily difficult.
Cataplexy can affect only part of the body or many muscle groups at once.
Milder episodes may involve:
- drooping eyelids;
- facial weakness;
- the jaw becoming slack;
- the head dropping forward;
- slurred or interrupted speech;
- objects slipping from the hands;
- knees briefly becoming weak.
More extensive episodes can cause someone to sink into a chair or fall to the ground.
Why does cataplexy happen in narcolepsy type 1?
Cataplexy is linked to disruption of orexin signaling, which normally helps stabilize wakefulness and muscle control.
Orexin, also called hypocretin, is a neuropeptide produced by neurons in the hypothalamus.
Most people with narcolepsy type 1 have lost many of the neurons that produce orexin. This makes the boundaries between wakefulness and REM sleep less stable.
During REM sleep, the brain normally suppresses most skeletal muscle activity. In cataplexy, elements of that REM-related muscle inhibition appear unexpectedly during wakefulness.
Strong emotions can activate neural pathways that make these episodes more likely.
This is why someone can remain mentally awake while temporarily losing muscle tone.
How long does a cataplexy episode usually last?
Cataplexy episodes are usually brief, often lasting seconds to a few minutes.
The exact duration varies.
Some episodes affect only one muscle group and disappear almost immediately. Others cause more extensive weakness and take longer to resolve.
After a typical episode, muscle control returns without the prolonged confusion that often follows some seizures.
If an event lasts much longer than your usual episodes, involves prolonged unconsciousness, breathing problems, or develops features that are new for you, it deserves medical assessment rather than being assumed to be cataplexy.
What should you do when you feel a cataplexy episode starting?
Move toward a safe position and away from immediate hazards if you are able to recognize an episode starting.
You could:
- sit down;
- lean against a stable surface;
- lower yourself carefully toward the floor;
- move away from stairs or sharp furniture;
- put down a hot, sharp, heavy, or breakable object if it is safe to do so.
The goal is to reduce injury if your muscle tone decreases further.
Some people recognize early signs such as facial weakness, changes in speech, knee weakness, or a familiar sensation that precedes a stronger episode.
If you notice a consistent warning pattern, recording it can help you explain your episodes more precisely during a sleep-specialist appointment.
What should you do if cataplexy happens while you are standing?
Lowering yourself into a stable position can reduce the risk of falling.
Do not rely on your legs continuing to support you if you recognize your usual cataplexy beginning.
A chair, wall, countertop, or floor may provide a safer position while the episode passes.
If you have experienced falls, head injuries, or episodes near stairs, traffic, water, hot surfaces, or machinery, consider discussing those situations specifically with your clinician.
Your environment can sometimes be adjusted to reduce injury risk while your medical care is reviewed.
What should you do if cataplexy happens while driving?
If you experience warning signs of cataplexy or overwhelming sleepiness while driving, stop driving as soon as you can do so safely.
Driving requires continuous muscle control, alertness, and rapid reactions. Both cataplexy and excessive daytime sleepiness can interfere with these abilities.
If recurrent cataplexy has occurred while driving, that is important information to discuss promptly with your sleep specialist.
Driving restrictions and reporting requirements also vary by country and region.
A clinician can discuss your individual situation, while your local licensing authority can provide the applicable legal requirements.
Do not assume that medication automatically makes driving safe at every time of day. mama health's guide to driving with narcolepsy in Germany covers fitness-to-drive rules in more detail, including how cataplexy specifically factors into that assessment.
What should you do during an episode if you are with someone experiencing cataplexy?
Focus on preventing injury and allowing the episode to pass without unnecessary intervention.
You can:
- help protect their head if they are falling;
- guide them toward the floor or a stable seated position if this can be done safely;
- move sharp, hot, or heavy objects away;
- give them physical space;
- speak calmly;
- observe how long the episode lasts.
Someone with cataplexy may still be able to hear you even if they cannot respond normally.
You do not need to shout, slap, shake, or force them to move.
Should you hold someone upright during cataplexy?
Usually, supporting them into a safe position is more useful than trying to keep them standing.
Trying to hold someone completely upright during sudden loss of muscle tone can make both people unstable.
If they are already falling, protecting the head and guiding the descent can help reduce injury.
Avoid forceful restraint.
Once the person is in a safe position, allow the episode to resolve.
Should you put anything in someone's mouth during cataplexy?
No. Do not put anything into someone's mouth during a cataplexy episode.
Cataplexy does not require an object in the mouth, and doing so can cause injury.
The same principle applies when someone is having a seizure: objects should not be placed in the mouth.
Instead, focus on keeping the surrounding area safe and observing the person's breathing, awareness, and recovery.
Is cataplexy the same as fainting?
No. Cataplexy and fainting are different events.
During typical cataplexy, awareness is preserved.
Fainting, or syncope, involves temporary loss of consciousness caused by reduced blood flow to the brain.
Cataplexy is also commonly linked to an emotional trigger and is associated with narcolepsy type 1.
Because unusual collapses can have many possible causes, a new episode should not automatically be labeled cataplexy without medical evaluation.
This is especially important if consciousness was lost.
Is cataplexy the same as a seizure?
No. Cataplexy is not a seizure, although the two can sometimes be confused based on appearance alone.
Features that more strongly suggest a typical cataplexy episode include:
- an emotional trigger;
- sudden loss of muscle tone;
- preserved awareness;
- a brief duration;
- rapid return to baseline afterward.
Seizures can present in many different ways, so there is no single symptom that separates every seizure from cataplexy.
However, prolonged confusion after an event, sustained rhythmic jerking, prolonged unresponsiveness, or other features that are not typical for someone's known cataplexy may require further assessment.
If you are unsure what an event was, medical evaluation is safer than assuming.
When is cataplexy usually not an emergency?
A brief, typical episode that resolves completely without injury generally does not require emergency care solely because cataplexy occurred.
For someone with an established diagnosis and a familiar pattern, the immediate priority is usually preventing injury and allowing the episode to pass.
However, frequency and impact still matter.
Episodes do not have to be emergencies to deserve discussion with a sleep specialist.
For example, cataplexy may be significantly affecting your life if you have begun avoiding:
- laughter;
- social situations;
- exercise;
- caring for children;
- carrying hot food or drinks;
- stairs;
- driving;
- work tasks;
- situations involving excitement or surprise.
That functional impact is useful clinical information.
When should you seek urgent or emergency medical help?
Seek urgent medical help when the event involves a serious injury or features that are not consistent with a person's usual cataplexy.
Examples include:
- significant head injury;
- severe bleeding;
- a suspected fracture;
- a serious burn;
- difficulty breathing;
- prolonged loss of consciousness;
- failure to recover normally after the episode;
- a first unexplained collapse when the cause is uncertain;
- seizure-like activity that is new or unusual;
- an episode occurring in water or another hazardous environment.
Emergency services may also be appropriate whenever you are unsure whether the person is breathing normally or whether another medical emergency is occurring.
Do not delay emergency care because someone has narcolepsy if the current event looks different from their usual episodes.
When should changing cataplexy patterns be discussed with a doctor?
A clear change in frequency, severity, duration, triggers, or injuries is worth discussing with the clinician who manages your narcolepsy.
Examples include:
- episodes becoming much more frequent;
- full-body collapses beginning after previously mild episodes;
- repeated falls;
- injuries;
- new episodes while driving;
- episodes that seem substantially longer than usual;
- muscle weakness occurring without the usual emotional triggers;
- uncertainty about whether the events are actually cataplexy.
Medication changes are also relevant.
Some medicines can influence cataplexy, and abrupt discontinuation of medicines that suppress cataplexy may cause symptoms to worsen or rebound.
Do not stop or change a prescription because of cataplexy without discussing it with your prescribing clinician.
What is status cataplecticus?
Status cataplecticus is a rare state involving unusually prolonged or repeated cataplexy.
It has been reported particularly after abrupt withdrawal of medicines that suppress REM-related symptoms.
Because prolonged or repeated loss of muscle tone can resemble other neurological events, it should not simply be managed at home when it falls outside someone's established pattern.
If episodes become prolonged, repetitive, or difficult to distinguish from another neurological problem, contact the treating clinician promptly or seek urgent evaluation depending on severity.
Why can cataplexy affect much more than physical safety?
Cataplexy can change how someone expresses emotion, participates socially, and approaches ordinary activities.
Experiences shared through mama health highlight a particularly difficult tension: the triggers are often normal and positive emotions.
Some describe becoming cautious about laughing intensely. Others describe anxiety about excitement, arguments, social events, physical affection, or situations where suddenly losing muscle tone would feel embarrassing or unsafe.
Recurring themes include:
- suppressing laughter;
- worrying about falling in public;
- avoiding situations where excitement is likely;
- feeling uncomfortable explaining episodes to friends or colleagues;
- uncertainty about whether mild facial or knee weakness “counts” as cataplexy;
- planning daily activities around the possibility of an episode;
- worrying about carrying children or hot objects;
- concerns about driving.
These experiences do not determine how another person's cataplexy will behave.
They do show why frequency alone may not capture its full effect.
One episode in a particularly hazardous or meaningful situation can matter more than several mild episodes at home.
Can cataplexy be treated?
Yes. Several medicines are approved for cataplexy associated with narcolepsy.
Treatment choices depend on age, symptoms, medical history, other prescriptions, possible side effects, access, and individual circumstances.
A sleep specialist can consider cataplexy separately from excessive daytime sleepiness because not every narcolepsy medication addresses both.
How is pitolisant used for cataplexy?
Pitolisant, sold as Wakix, is approved in the United States for excessive daytime sleepiness or cataplexy associated with narcolepsy in people aged 6 years and older.
Pitolisant is a histamine H3 receptor antagonist/inverse agonist.
In February 2026, the FDA expanded its indication to include cataplexy in children aged 6 years and older, meaning the current U.S. indication now covers EDS or cataplexy in people 6 years and older with narcolepsy.
Pitolisant is not federally scheduled as a controlled substance.
Whether it is appropriate for a particular person still requires clinician review, including consideration of medication interactions and cardiac risk factors.
How are oxybates used for cataplexy?
Oxybate medicines are established treatments for cataplexy and excessive daytime sleepiness associated with narcolepsy.
Examples include:
- sodium oxybate (Xyrem);
- calcium, magnesium, potassium, and sodium oxybates (Xywav);
- extended-release sodium oxybate (Lumryz).
Xywav is approved for cataplexy or excessive daytime sleepiness associated with narcolepsy in people aged 7 years and older.
Lumryz is also approved for cataplexy or excessive daytime sleepiness associated with narcolepsy in people aged 7 years and older. It is taken once nightly, unlike older immediate-release oxybate regimens that require another dose during the night.
Oxybates are central nervous system depressants and have important safety precautions. Certain products are available through restricted distribution programs in the United States because of risks including central nervous system depression, abuse, and misuse.
They must be used exactly as prescribed.
Are antidepressants used for cataplexy?
Some antidepressants have historically been used off-label to suppress cataplexy.
Examples discussed in sleep medicine include certain serotonin-norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors, and older tricyclic antidepressants.
The evidence base is more limited than for several FDA-approved cataplexy treatments, and these medicines are not all specifically approved for cataplexy.
They also require careful prescribing because abrupt discontinuation of some REM-suppressing medicines can cause cataplexy to rebound.
If an antidepressant is part of your medication list, include it when discussing changes in cataplexy with your sleep specialist.
Do not stop it abruptly unless your clinician provides a plan.
What is oveporexton, and can it help cataplexy?
Oveporexton, sold as Orzeyful in the United States, is a new orexin receptor 2 agonist approved for adults with narcolepsy type 1.
The FDA approved it on August 5, 2026.
It is the first approved medicine that directly restores orexin receptor signaling, targeting the biological pathway disrupted in NT1 rather than focusing on one symptom alone.
The FDA approval encompasses narcolepsy type 1 as a disorder, including its defining symptoms such as excessive daytime sleepiness and cataplexy.
Oveporexton is not currently FDA-approved for narcolepsy type 2.
At the time of the approval announcement, U.S. commercial availability was expected after completion of DEA scheduling. Current access may therefore differ by location and timing.
A sleep specialist or pharmacist can provide up-to-date availability information and discuss whether it is relevant to your circumstances.
Do modafinil, armodafinil, or solriamfetol treat cataplexy?
These medicines are primarily used to address excessive daytime sleepiness rather than cataplexy.
That distinction matters because narcolepsy can involve several symptoms at once.
Someone may experience better daytime alertness while cataplexy remains disruptive.
If your treatment appears to help sleepiness but muscle-weakness episodes continue, you could describe that distinction clearly to your sleep specialist.
It is not a reason to change medication yourself.
It is useful information for a treatment review.
What should you record about cataplexy before a sleep-specialist appointment?
Record what happened before, during, and after each episode as accurately as you can.
Useful information can include:
- date and approximate time;
- emotional trigger;
- which muscles were affected;
- whether you remained aware;
- approximate duration;
- whether you fell;
- whether you were injured;
- what you were doing at the time;
- whether driving or another safety-sensitive activity was involved;
- medication timing;
- recent medication changes;
- how the episode affected what you did afterward.
You do not need a perfect diary.
Even a simple record can reveal information that is difficult to remember during a short appointment.
Why does the impact of cataplexy matter as much as the number of episodes?
Frequency alone does not explain how much cataplexy affects daily life.
Two people experiencing the same number of episodes may face very different consequences.
A brief facial episode at home is different from knee weakness while carrying a child, standing on stairs, cooking over a hot stove, or crossing a street.
It can therefore be useful to record what the episode prevented you from doing or made you afraid to do, not just how many occurred.
For example:
- Have you stopped driving?
- Are you avoiding certain social situations?
- Do you avoid holding a child while standing?
- Have you changed work duties?
- Are you suppressing laughter or excitement?
- Have falls or near-falls occurred?
These details help describe your experience without requiring you to judge which treatment should change.
What questions could you bring to your next appointment?
Specific questions can help make cataplexy a distinct part of your narcolepsy discussion.
You could consider asking:
- Do the episodes I am describing fit the usual pattern of cataplexy?
- What details would help you understand their severity?
- Which of my current medicines address cataplexy?
- Which medicines primarily address daytime sleepiness?
- Could a recent medication change explain why my episodes changed?
- Are there treatments specifically approved for cataplexy that are relevant to my situation?
- What safety precautions make sense given where my episodes occur?
- What should I do if an episode lasts longer than usual?
- What symptoms would mean that an episode needs urgent evaluation?
- If I have narcolepsy type 1, is oveporexton relevant to my medical situation?
- What should I know about driving with my current cataplexy pattern?
These are discussion prompts rather than instructions to start, stop, or change treatment.
How can mama health help you organize information about cataplexy?
mama health is a free app for everything your condition asks of you, grounded in medical science and the experience of others, so you don't have to figure it out alone.
You can use mama health to:
- Ask anything. Answers are shaped by trusted sources, the history you choose to share, and thousands like you.
- Find specialists and care near you, wherever you are.
- Understand your labs, prescriptions, and reports, read against the history you have shared and explained in accessible educational language.
- Record and reflect on cataplexy and other daily experiences, including possible triggers, muscle weakness, sleepiness, medication timing, injuries, and questions.
- Turn what you record into structured reports you can take to your doctor's appointment.
For cataplexy, you might record whether an episode followed laughter or another emotion, which muscles were affected, whether you remained aware, approximately how long it lasted, and whether it changed what you felt safe doing afterward.
Experiences from thousands like you can also provide useful context for experiences that are difficult to put into words. You can see how others describe subtle cataplexy, the questions they prepare for appointments, and the practical adjustments they make around daily activities.
Someone else's experience cannot determine whether an event you had was cataplexy or tell you which treatment is appropriate.
mama health can help you organize information, understand educational material, and prepare questions for your doctor. It does not diagnose cataplexy, determine whether an episode is an emergency, or recommend changes to medication.
What is the bottom line during a cataplexy episode?
The immediate priority is safety: reduce the risk of falling or injury and allow a typical episode to pass.
If you experience cataplexy:
- move toward a safe position when possible;
- lower yourself rather than trying to remain standing;
- move away from obvious hazards;
- avoid driving if an episode or warning symptoms are occurring.
If you are with someone:
- protect them from injury;
- help them into a safe position if needed;
- do not restrain them;
- do not put anything in their mouth;
- stay calm and observe their recovery.
Seek urgent medical help when there is a serious injury, breathing difficulty, prolonged loss of consciousness, an unexplained first collapse, or an event that looks substantially different from the person's known cataplexy.
Beyond the individual episode, cataplexy is also worth discussing as its own part of narcolepsy care.
You do not need to measure its importance only by how often it happens.
If cataplexy is changing what you feel able to do, where you go, how you express emotion, or whether you feel safe in ordinary situations, that is meaningful information to bring to your sleep specialist.
Disclaimer: This content is informational and not a medical device. mama health offers information and support and does not replace a doctor.
This content is informational and not a medical device.
mama health offers information and support and does not replace a doctor.
- American Academy of Sleep Medicine. Treatment of Central Disorders of Hypersomnolence: An American Academy of Sleep Medicine Clinical Practice Guideline. Provides evidence-based recommendations for pharmacological treatment of narcolepsy, including pitolisant and sodium oxybate.
- Dauvilliers Y, Siegel JM, Lopez R, Torontali ZA, Peever JH. Cataplexy—clinical aspects, pathophysiology and management strategy. Nature Reviews Neurology. Reviews the defining features, triggers, neurobiology, and treatment of cataplexy.
- U.S. Food and Drug Administration. WAKIX (pitolisant) supplemental approval. February 13, 2026. The FDA expanded the indication to treatment of cataplexy in people aged 6 years and older with narcolepsy.
- U.S. Food and Drug Administration. First Generic Drug Approvals, 2026. Confirms the current pitolisant indication as treatment of excessive daytime sleepiness or cataplexy in people aged 6 years and older with narcolepsy.
- U.S. Food and Drug Administration. Clinical Superiority Findings: Lumryz and Xywav. Current FDA information confirms that Lumryz and Xywav are approved for cataplexy or excessive daytime sleepiness associated with narcolepsy in people aged 7 years and older and describes the once-nightly dosing advantage of Lumryz.
- U.S. Food and Drug Administration. XYWAV orphan drug designation and approval information. Confirms its indication for cataplexy or excessive daytime sleepiness associated with narcolepsy in people aged 7 years and older.
- U.S. Food and Drug Administration. LUMRYZ orphan drug designation and approval information. Confirms its current indication for cataplexy or excessive daytime sleepiness associated with narcolepsy in people aged 7 years and older.
- U.S. Food and Drug Administration. FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms. August 5, 2026. Orzeyful (oveporexton) was approved for adults with narcolepsy type 1 and is the first approved therapy to directly restore orexin signaling.
- Takeda. U.S. FDA Approves ORZEYFUL for Adults With Narcolepsy Type 1. August 5, 2026. The company stated that U.S. availability was expected following completion of DEA scheduling.
